PHYTOHEALTH CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20 TWD | +1.01% |
|
-0.25% | -7.83% |
| Sales 2022 | 135M 4.16M | Sales 2023 | 162M 4.99M | Capitalization | 4.31B 132M |
|---|---|---|---|---|---|
| Net income 2022 | -79M -2.43M | Net income 2023 | -47M -1.44M | EV / Sales 2022 | 18.2 x |
| Net cash position 2022 | 1.33B 40.85M | Net cash position 2023 | 1.24B 38.01M | EV / Sales 2023 | 18.9 x |
| P/E ratio 2022 |
-47.8
x | P/E ratio 2023 |
-91.5
x | Employees | 84 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 76.02% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +1.01% | ||
| 1 week | -0.25% | ||
| Current month | -2.91% | ||
| 1 month | -2.91% | ||
| 3 months | -7.41% | ||
| 6 months | +0.50% | ||
| Current year | -7.83% |
1 week
19.20
20.10
1 month
19.2021.15
Current year
19.2023.50
1 year
18.9525.25
3 years
17.0527.95
5 years
10.2541.05
10 years
10.2548.70
| Managers | Title | Age | Since |
|---|---|---|---|
I Lin Lee
CEO | Chief Executive Officer | - | 17-06-12 |
Chih Yuan Huang
DFI | Director of Finance/CFO | - | 21-05-10 |
Teng Hsu Wang
CTO | Chief Tech/Sci/R&D Officer | - | 21-07-29 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ching Chung Tsai
BRD | Director/Board Member | - | 14-06-11 |
Yue Ju Lai
BRD | Director/Board Member | - | 02-05-19 |
Yi Li Lee
CHM | Chairman | 53 | 02-05-19 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 20 | +1.01% | 186,840 |
| 24-04-23 | 19.8 | +1.80% | 181,585 |
| 24-04-22 | 19.45 | 0.00% | 168,215 |
| 24-04-19 | 19.45 | -2.51% | 473,586 |
| 24-04-18 | 19.95 | -0.50% | 168,436 |
End-of-day quote Taiwan S.E., April 23, 2024
More quotes
PhytoHealth Corporation is a Taiwan company principally engaged in the research, development and manufacture of new botanical drugs. The Company's main products include western medicines, Chinese herbal medicines, cosmetics, Class B drugs and supplementary food. The Company also provides pharmaceutical consulting services. The Company distributes its products in domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-05-06
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -7.83% | 122M | |
| -2.86% | 87.31B | |
| +3.95% | 40.86B | |
| -21.94% | 29.36B | |
| +55.70% | 24.49B | |
| -5.41% | 17.31B | |
| -44.23% | 11.26B | |
| -17.60% | 11.62B | |
| -13.96% | 11.31B | |
| +7.49% | 8.31B |
- Stock Market
- Equities
- 4108 Stock
